Matthew Ebbel serves as Executive at AdaptHealth Corp., where they oversee executive responsibilities. Since joining the company, Matthew Ebbel has executed 8 insider transactions totaling $6.3M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 14, 2022 involved purchasing 99,900 shares valued at $1.7M.
Matthew Ebbel currently holds 100,000 shares of AdaptHealth Corp. (AHCO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Ebbel has been a net buyer of AHCO stock. They have purchased $6.3M and sold $0 worth of shares.
Matthew Ebbel's most recent insider trade was on Jun 14, 2022, when they purchased 99,900 shares at $17.07 per share.
Get notified when new Form 4 filings are submitted
| $16.95 |
| Discretionary |
| May 24, 2022 | AHCO | $1.7M | Purchase | 100,000 | $17.27 | Discretionary |
| May 23, 2022 | AHCO | $162.2K | Purchase | 9,300 | $17.44 | Discretionary |
| May 20, 2022 | AHCO | $1.7M | Purchase | 100,000 | $17.33 | Discretionary |
| May 16, 2022 | AHCO | $350.4K | Purchase | 21,632 | $16.20 | Discretionary |
| Mar 14, 2022 | AHCO | $381.3K | Purchase | 25,000 | $15.25 | Discretionary |
| Mar 11, 2022 | AHCO | $271.0K | Purchase | 17,486 | $15.50 | Discretionary |